Specialty Pharmacy

Top news of the day from across the health care landscape.

Clinicians rely on a limited number of drugs to help patients with type 2 diabetes.

Superior progression-free survival achieved with cabozantinib over sunitinib in patients with metastatic renal cell carcinoma.

Supplements given to prostate cancer patients following radiotherapy could harm disease outcomes.

A component found in red wine and grapes may help manage inflammation caused by a bacterial pathogen associated with upper respiratory tract inflammatory diseases.

Immunotherapy showed promise in first- and second-line therapy for patients with metastatic bladder cancer.

Survey findings show a high level of integration of palliative care in advanced cancer patients.

Top news of the day from across the health care landscape.

Researchers examine strategies to control the spread of HIV.

Performance-based contracting is challenging the current paradigm in specialty pharmacy.

A treatment for multiple sclerosis that treats the most common form of the disease may help reverse some physical disabilities.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how the growing population of older Americans could impact the specialty pharmacy landscape.

No change in prostate-specific antigen tests for cancer was found before and after new screening guidelines.

Researchers created a technique that targets HIV reservoirs.

Top news of the day from across the health care landscape.

Researchers examine interventions that may improve adherence in chronic viral hepatitis care.

CDC now recommends a 2-dose series of the HPV vaccination in children 11 to 12 years of age.

Top news of the week in oncology and cancer drug development.

New data indicates men of African American and Hispanic descent are less likely to undergo therapy for prostate cancer compared with Caucasian men.

A small proportion of HIV-infected children do not develop AIDS by controlling the virus in a different way than infected adults who remain disease-free.

Entyvio is a humanized monoclonal antibody for patients with moderate-to-severe ulcerative colitis and Crohn’s disease.

Targeting the uracil-DNA glycosylase enzyme may help treat certain types of non-Hodgkin’s lymphoma.

Top news of the day from across the health care landscape.

Top articles of the week on Specialty Pharmacy Times.

Efficacy and safety data shows encouraging results for rucaparib in BRCA-mutation ovarian cancer.

Broad-spectrum HIV-targeting monoclonal antibodies may lead to a cure for HIV in the future.

Recent findings suggest the implementation of intervention programs that target young males of a lower socio-economic status, non-cancer and cancer survivors, and cervical cancer survivors to help reduce the consumption of sugary drinks and added sugar.

Treating financial toxicity in cancer patients similarly to other side effects could improve outcomes.

Lartruvo with doxorubicin significantly improves overall survival in patients with soft tissue sarcoma.

Patients with Crohn’s disease achieve highest clinical response and remission rates during an early study.